Alessandro Massimo Gianni (M Figini, Mariangela Figini)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Topics

Recombinant Human

Prostate Cancer

Top Venues

Journal of experimental & clinical cancer research : CR

This page only lists publications with an associated author ORCID identifier.

Publications

James F Spicer, Bristi Basu, Ana Montes, Udai Banerji, Rebecca S Kristeleit, Rowan E Miller, Gareth J Veal, Christopher J Corrigan, Stephen J Till, Alessandro Massimo Gianni, Silvana Canevari, Claire Barton, Paul Jones, Sarah Mellor, Simon Carroll, Chris Selkirk, George Nintos, Vineet Kwatra, Ionut-Gabriel Funingana, Gary J Doherty, Hannah J Gould, Giulia Pellizzari, Mano Nakamura, Kristina M Ilieva, Atousa Khiabany, Chara Stavraka, Jitesh Chauhan, Cheryl Gillett, Sarah E Pinder, Heather J Bax, Debra H Josephs, Sophia N Karagiannis
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial. Nature communications 14 (1) (2023)
Giulia Pellizzari, Olivier Martinez, Silvia Crescioli, Robert Page, Ashley Di Meo, Silvia Mele, Giulia Chiaruttini, Jan Hoinka, Ihor Batruch, Ioannis Prassas, Melanie Grandits, Jacobo López-Abente, Eva Bugallo-Blanco, Malcolm Ward, Heather J Bax, Elise French, Anthony Cheung, Sara Lombardi, Alessandro Massimo Gianni, Katie E Lacy, Eleftherios P Diamandis, Debra H Josephs, James F Spicer, Sophie Papa, Sophia N Karagiannis
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2. Journal for immunotherapy of cancer 9 (6) (2022)
Ciniselli Chiara Maura, Mara Lecchi, Alessandro Massimo Gianni, Cecilia C Melani, Maria Grazia Daidone, Daniele Morelli, Emanuela Zito, Giovanni Apolone, Paolo Verderio
COVID-19 Vaccination in Health Care Workers in Italy: A Literature Review and a Report from a Comprehensive Cancer Center. Vaccines 10 (5) (2022)
Simone Camelliti, Valentino Le Noci, Francesca Bianchi, Chiara Storti, Francesca Arnaboldi, Alessandra Cataldo, Serena Indino, Elena Jachetti, Alessandro Massimo Gianni, Mario Paolo Colombo, Andrea Balsari, Nicoletta Gagliano, Elda Tagliabue, Lucia Sfondrini, Michele Sommariva
Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain. Cancers 13 (16) (2021)
Barbara Frigerio, Elena Luison, Alessandro Desideri, Federico Iacovelli, Chiara Camisaschi, Ettore C Seregni, Silvana Canevari, Alessandro Massimo Gianni
Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review. Biomedicines 9 (12) (2021)
Chiara Maura Ciniselli, Arianna Micali, Loris De Cecco, Paola Notti, Valentina Sinno, Elena Luison, Cecilia C Melani, Maria Grazia Daidone, Giovanni Apolone, Paolo Verderio, Alessandro Massimo Gianni
SARS-CoV-2 Serology Monitoring of a Cancer Center Staff in the Pandemic Most Infected Italian Region. Cancers 13 (5) (2021)
Debora Carpanese, Guillermina Ferro-Flores, Blanca Ocampo-Garcia, Clara Santos-Cuevas, Nicola Salvarese, Alessandro Massimo Gianni, Giulio Fracasso, Laura De Nardo, Cristina Bolzati, Antonio Rosato, Laura Melendez-Alafort
Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen. Scientific reports 10 (1) (2020)
Mano Nakamura, Elmira Amiri Souri, Gabriel Osborn, Roman Laddach, Jitesh Chauhan, Chara Stavraka, Sara Lombardi, Anna Black, Atousa Khiabany, Duaa O Khair, Alessandro Massimo Gianni, Anna Winship, Sharmistha Ghosh, Ana Montes, James F Spicer, Heather J Bax, Debra H Josephs, Katie E Lacy, Sophia Tsoka, Sophia N Karagiannis
IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype. Cancers 12 (11) (2020)
B Frigerio, S Morlino, E Luison, E Seregni, A Lorenzoni, A Satta, R Valdagni, A Bogni, C Chiesa, M Mira, S Canevari, A Alessi, Alessandro Massimo Gianni
Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle. Journal of experimental & clinical cancer research : CR 38 (1) (2019)
Alessandro Satta, Mezzanzanica Delia, Francesco Caroli, Barbara Frigerio, Massimo Di Nicola, Roland E Kontermann, Federico Iacovelli, Alessandro Desideri, Silvana Canevari, Alessandro Massimo Gianni
Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells. mAbs 10 (7) (2018)